Northwestern Mutual Wealth Management
INFI

Northwestern Mutual Wealth Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-30
Closed – – 2553
2016
Q3 		$0 Buy
+30
New +$46 ﹤0.01% 2368

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northwestern Mutual Wealth Management's INFI Position: Q4 2016 in Review

Northwestern Mutual Wealth Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2016, closing a stake of 30 shares.

Northwestern Mutual Wealth Management first reported a position in INFI in Q3 2016 and held it in 1 quarter. The position peaked at $0 in Q3 2016. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

  • Northwestern Mutual Wealth Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 30 Infinity Pharmaceuticals, Inc. shares in Q4 2016.
  • Northwestern Mutual Wealth Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2016 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Infinity Pharmaceuticals, Inc. position peaked at $0 in Q3 2016.
  • 94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2016, filed 15 Feb 2017.